Anti-TLR4/ ARMD10/ CD284 monoclonal antibody

Anti-TLR4/ ARMD10/ CD284 antibody for FACS & in-vivo assay

Target products collectionGo to TLR4/TLR4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T81443-Ab-1/ GM-Tg-hg-T81443-Ab-2Anti-Human TLR4 monoclonal antibodyHuman
GM-Tg-rg-T81443-Ab-1/ GM-Tg-rg-T81443-Ab-2Anti-Rat TLR4 monoclonal antibodyRat
GM-Tg-mg-T81443-Ab-1/ GM-Tg-mg-T81443-Ab-2Anti-Mouse TLR4 monoclonal antibodyMouse
GM-Tg-cynog-T81443-Ab-1/ GM-Tg-cynog-T81443-Ab-2Anti-Cynomolgus/ Rhesus macaque TLR4 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T81443-Ab-1/ GM-Tg-felg-T81443-Ab-2Anti-Feline TLR4 monoclonal antibodyFeline
GM-Tg-cang-T81443-Ab-1/ GM-Tg-cang-T81443-Ab-2Anti-Canine TLR4 monoclonal antibodyCanine
GM-Tg-bovg-T81443-Ab-1/ GM-Tg-bovg-T81443-Ab-2Anti-Bovine TLR4 monoclonal antibodyBovine
GM-Tg-equg-T81443-Ab-1/ GM-Tg-equg-T81443-Ab-2Anti-Equine TLR4 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T81443-Ab-1/ GM-Tg-hg-T81443-Ab-2; GM-Tg-rg-T81443-Ab-1/ GM-Tg-rg-T81443-Ab-2;
GM-Tg-mg-T81443-Ab-1/ GM-Tg-mg-T81443-Ab-2; GM-Tg-cynog-T81443-Ab-1/ GM-Tg-cynog-T81443-Ab-2;
GM-Tg-felg-T81443-Ab-1/ GM-Tg-felg-T81443-Ab-2; GM-Tg-cang-T81443-Ab-1/ GM-Tg-cang-T81443-Ab-2;
GM-Tg-bovg-T81443-Ab-1/ GM-Tg-bovg-T81443-Ab-2; GM-Tg-equg-T81443-Ab-1/ GM-Tg-equg-T81443-Ab-2
Products NameAnti-TLR4 monoclonal antibody
Formatmab
Target NameTLR4
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-TLR4 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species TLR4/ ARMD10/ CD284 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLV000034human TLR4 Lentivirus plasmid
    ORF Viral VectorvGMLV000034human TLR4 Lentivirus particle
    ORF Viral VectorpGMAD000527house mouse Tlr4 Adenovirus plasmid
    ORF Viral VectorpGMAAV000078mouse Tlr4 AAV plasmid
    ORF Viral VectorvGMAD000527house mouse Tlr4 Adenovirus particle
    ORF Viral VectorvGMAAV000078mouse Tlr4 AAV particle


    Target information

    Target IDGM-T81443
    Target NameTLR4
    Gene ID7099,21898,29260,574360,403417,493698,281536,100066890
    Gene Symbol and SynonymsARMD10,CD284,hToll,Lps,Ly87,Ran/M1,Rasl2-8,TLR-4,TLR4,TOLL
    Uniprot AccessionO00206,Q9QX05,P58727,Q9GL65,Q9MYW3
    Uniprot Entry NameTLR4_HUMAN,TLR4_RAT,TLR4_FELCA,TLR4_BOVIN,TLR4_HORSE
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target, Immuno-oncology Target
    DiseaseCancer
    Gene EnsemblENSG00000136869
    Target ClassificationCheckpoint-Immuno Oncology, Tumor-associated antigen (TAA)

    The target: TLR4, gene name: TLR4, also named as ARMD10, CD284, TLR-4, TOLL. The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. In silico studies have found a particularly strong binding of surface TLR4 with the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of Coronavirus disease-2019 (COVID-19). This receptor has also been implicated in signal transduction events induced by lipopolysaccharide (LPS) found in most gram-negative bacteria. Mutations in this gene have been associated with differences in LPS responsiveness, and with susceptibility to age-related macular degeneration. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2020].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.